Prevalence and risk factors for functional iron deficiency in children with chronic kidney disease

Bishnu Kumar Thapa1, Prateek Bhatia2, Jitendra Meena1

  • 1Pediatric Nephrology Unit, Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Insights

Functional iron deficiency (FID) affects one-fourth of pediatric chronic kidney disease (CKD) patients. Lower estimated glomerular filtration rate and mineral bone disease are key risk factors for FID in children with CKD.

Area of Science:

  • Pediatric Nephrology
  • Hematology
  • Iron Metabolism

Background:

  • Anemia in chronic kidney disease (CKD) is a complex condition with multiple contributing factors.
  • Functional iron deficiency (FID), characterized by impaired iron transport to the bone marrow, is a significant etiological factor in anemia.
  • Understanding FID prevalence and risk factors in pediatric CKD is crucial for effective management.

Purpose of the Study:

  • To determine the prevalence of functional iron deficiency (FID) in children with chronic kidney disease (CKD).
  • To identify associated risk factors for FID in this pediatric population.
  • To inform clinical practice regarding anemia management in pediatric CKD.

Main Methods:

  • A cross-sectional study involving children aged ≤12 years with CKD was conducted.
  • Exclusion criteria included patients on erythropoietin or maintenance dialysis.
  • Laboratory parameters such as complete blood count, red blood cell indices, and serum ferritin were analyzed.

Main Results:

  • Anemia was prevalent in 63% of the 174 pediatric CKD patients studied.
  • Absolute iron deficiency was observed in 38% of patients, with FID identified in 25%.
  • Lower estimated glomerular filtration rate and mineral bone disease were significantly associated with FID.

Conclusions:

  • Functional iron deficiency (FID) is a notable contributor to anemia in pediatric chronic kidney disease (CKD), affecting approximately one-fourth of patients.
  • FID should be considered in pediatric CKD patients with anemia unresponsive to standard treatments.
  • Further research is needed to elucidate the long-term impact of FID on patient outcomes, including quality of life and mortality.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
64
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
57
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
71
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
146
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
60
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
69